Phase 1 Clinical Trial Met All Primary and Secondary Endpoints and Demonstrated Positive Safety, Pharmacokinetics, and ...

Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.

Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, ...

Dyne’s exon-skipping therapy zeleciment rostudirsen resulted in an approximately sevenfold increase in dystrophin levels at ...

The FDA has cleared the use of GSK’s Blujepa for the treatment of uncomplicated urogenital gonorrhea, unlocking the first new ...

A vial of the measles, mumps and rubella vaccine is on display at the Lubbock Health Department on Feb. 26, 2025, in Lubbock, ...

The average salary of pre-K teachers increased from $63,600 in 2024 to about $66,800 in 2025, or roughly 5%, according to ...

FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against ...

Igyxos Biotherapeutics is dedicated to developing innovative treatments for infertility in both men and women. Its lead asset, IGX12, is a first-in-class potentiating monoclonal antibody designed to ...

One might do a double-take looking at the list of seniors at Upper St. Clair High School. There are 16 sets of twins in the ...

The release of Phase III Stage 1 data for gotistobart (BNT316/ONC-392) at NACLC 2025 marks one of the most significant ...